Aims and Objectives. Injecting is the most hazardous way of taking drugs. It is the main source of both the short- and long-term risks of drug related death. Needle syringe provision and harm reduction initiatives are developed within a wider approach that advocates the following aims: ● Reduce the potential ▇▇▇▇▇ associated with active injecting drug use by providing sterile equipment. ● Reduce the prevalence of Blood Borne Viruses (BBV) and infections associated with injecting drug users and the local communities. ● Increase treatment knowledge of injecting drug users not currently engaged with treatment services. ● To maximise the access and retention of all service users, especially the highly socially excluded. ● To contribute to the reduction of drug-related deaths among injecting drug users. ● To reduce the rate of sharing and other high risk injecting behaviours. ● Reduce the cost of primary and secondary care caused by injecting drug use. It is expected that all needle syringe provision transactions will take place within the context of offering a user-friendly, non-judgemental, service user-centred and confidential harm reduction focused service.
Appears in 3 contracts
Sources: Service Level Agreement, Service Level Agreement, Service Level Agreement